Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes
- PMID: 19462421
- DOI: 10.1002/ibd.20986
Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes
Abstract
Background: The accuracy of noninvasive markers for the detection of endoscopically active ulcerative colitis (UC) according the Rachmilewitz Score is so far unknown. The aim was to evaluate the correlation between endoscopic disease activity and fecal calprotectin, Clinical Activity Index, C-reactive protein (CRP), and blood leukocytes.
Methods: UC patients undergoing colonoscopy were prospectively enrolled and scored independently according the endoscopic and clinical part of the Rachmilewitz Index. Patients and controls provided fecal and blood samples for measuring calprotectin, CRP, and leukocytes.
Results: Values in UC patients (n = 134) compared to controls (n = 48): calprotectin: 396 ± 351 versus 18.1 ± 5 μg/g, CRP 16 ± 13 versus 3 ± 2 mg/L, blood leukocytes 9.9 ± 3.5 versus 5.4 ± 1.9 g/L (all P < 0.001). Endoscopic disease activity correlated closest with calprotectin (Spearman's rank correlation coefficient r = 0.834), followed by Clinical Activity Index (r = 0.672), CRP (r = 0.503), and leukocytes (r = 0.461). Calprotectin levels were significantly lower in UC patients with inactive disease (endoscopic score 0-3, calprotectin 42 ± 38 μg/g), compared to patients with mild (score 4-6, calprotectin 210 ± 121 μg/g, P < 0.001), moderate (score 7-9, calprotectin 392 ± 246 μg/g, P = 0.002), and severe disease (score 10-12, calprotectin 730 ± 291 μg/g, P < 0.001). The overall accuracy for the detection of endoscopically active disease (score ≥4) was 89% for calprotectin, 73% for Clinical Activity Index, 62% for elevated CRP, and 60% for leukocytosis.
Conclusions: Fecal calprotectin correlated closest with endoscopic disease activity, followed by Clinical Activity Index, CRP, and blood leukocytes. Furthermore, fecal calprotectin was the only marker that reliably discriminated inactive from mild, moderate, and highly active disease, which emphasizes its usefulness for activity monitoring.
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.
Similar articles
-
Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.Am J Gastroenterol. 2010 Jan;105(1):162-9. doi: 10.1038/ajg.2009.545. Epub 2009 Sep 15. Am J Gastroenterol. 2010. PMID: 19755969
-
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.Inflamm Bowel Dis. 2013 Feb;19(2):332-41. doi: 10.1097/MIB.0b013e3182810066. Inflamm Bowel Dis. 2013. PMID: 23328771 Clinical Trial.
-
Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.World J Gastroenterol. 2018 Oct 14;24(38):4384-4392. doi: 10.3748/wjg.v24.i38.4384. World J Gastroenterol. 2018. PMID: 30344422 Free PMC article.
-
Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.J Gastrointestin Liver Dis. 2018 Sep;27(3):299-306. doi: 10.15403/jgld.2014.1121.273.pti. J Gastrointestin Liver Dis. 2018. PMID: 30240474
-
Review article: faecal calprotectin and histologic remission in ulcerative colitis.Aliment Pharmacol Ther. 2020 Apr;51(7):689-698. doi: 10.1111/apt.15662. Epub 2020 Feb 12. Aliment Pharmacol Ther. 2020. PMID: 32048751
Cited by
-
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.Clin Gastroenterol Hepatol. 2021 Nov;19(11):2333-2342. doi: 10.1016/j.cgh.2020.08.019. Epub 2020 Aug 13. Clin Gastroenterol Hepatol. 2021. PMID: 32801008 Free PMC article.
-
Methods to determine intestinal permeability and bacterial translocation during liver disease.J Immunol Methods. 2015 Jun;421:44-53. doi: 10.1016/j.jim.2014.12.015. Epub 2015 Jan 13. J Immunol Methods. 2015. PMID: 25595554 Free PMC article. Review.
-
Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis.BMC Gastroenterol. 2022 Feb 27;22(1):83. doi: 10.1186/s12876-022-02178-0. BMC Gastroenterol. 2022. PMID: 35220941 Free PMC article.
-
Can the CalproQuest predict a positive Calprotectin test? A prospective diagnostic study.PLoS One. 2019 Nov 21;14(11):e0224961. doi: 10.1371/journal.pone.0224961. eCollection 2019. PLoS One. 2019. PMID: 31751360 Free PMC article. Clinical Trial.
-
Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program.Inflamm Bowel Dis. 2023 Jan 5;29(1):51-61. doi: 10.1093/ibd/izac061. Inflamm Bowel Dis. 2023. PMID: 35380664 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous